Nandrolone decanoate: Pharmacological properties and therapeutic use in osteoporosis

@article{Geusens1995NandroloneDP,
  title={Nandrolone decanoate: Pharmacological properties and therapeutic use in osteoporosis},
  author={Prof. Dr. P. Geusens},
  journal={Clinical Rheumatology},
  year={1995},
  volume={14},
  pages={32-39}
}
  • P. D. P. Geusens
  • Published 1 September 1995
  • Medicine, Biology
  • Clinical Rheumatology
SummaryThe therapeutic profile on bone of nandrolone decanoate is that of inhibitor of bone resorption with temporary increase in bone formation, followed by an absence of suppression of bone formation, indicating uncoupling of bone resorption and formation. This results is an increase in bone mineral content at the proximal and distal radius, and in some patients at the lumbar spine. Furthermore, nandrolone decanoate increases calcium balance and muscle mass, diminishes vertebral pain and… 

The effect of nandrolone decanoate on bone mineral density, muscle mass, and hemoglobin levels in elderly women with osteoporosis: a double-blind, randomized, placebo-controlled clinical trial.

ND increased BMD, hemoglobin levels, and muscle mass, and bone mineral density, and reduced the vertebral fracture rate of elderly osteoporotic women.

Österreichischer Leitfaden zur medikamentösen Therapie der postmenopausalen Osteoporose – Update 2009

There is no evidence that a combination of two or more of these drugs could improve anti-fracture potency, however, treatment with PTH should be followed by the treatment with an anticatabolic drug such as bisphosphonates.

Nandrolone decanoate in induced fracture nonunion with vascular deficit in rat model: morphological aspects

The anabolic steroid nandrolone decanoate improved bone mass and regeneration without affecting collagen production and therefore has potential for improving outcomes for atrophic fracture nonunion.

Efeitos do metoprolol sobre as alterações histomorfológicas do coração produzidas pelo decanoato de nandrolona em ratos

The anabolic androgenic steroids (AAS) came from testosterone, with restricted use in medicine in some specific clinical conditions, and when correctly administrated are well tolerated. However,

Anabolic Androgenic Steroids in Orthopaedic Surgery: Current Concepts and Clinical Applications

A comprehensive overview of the current status of AAS applications in orthopaedic surgery, with an emphasis on preclinical data, clinical studies, and future directions is provided.

Beyond testosterone cypionate: evidence behind the use of nandrolone in male health and wellness

  • M. PanJ. Kovac
  • Biology, Medicine
    Translational andrology and urology
  • 2016
An anabolic steroid, 19-nortestosterone (i.e., nandrolone, deca-durabolin) has a higher myotrophic: androgenic ratio resulting in improved effects on muscle mass and animal models have suggested application in the improvement of joint healing following rotator cuff repair.

The Impact of Nandrolone Decanoate in the Osseointegration of Dental Implants in a Rabbit Model: Histological and Micro-Radiographic Results

The anabolic steroid nandrolone decanoate affects the healing processes of the peri-implant bone and therefore has the potential to improve the outcomes of implant treatment in medically complex patients.

Immediate and residual effects of low-dose nandrolone decanoate and treadmill training on adipose and reproductive tissues of male Wistar rats

The effects of training on fat and muscle were not maintained after detraining, but low-dose ND had persistent effects on the reproductive structures, and the anabolic action of ND on skeletal muscle was enhanced by training.

Nandrolone: a multi-faceted doping agent.

A set of strict identification criteria is applied to judge correctly an analytical finding of nandrolone metabolites, and the possible influence of interfering drugs, urine storage or natural production is taken into account by applying appropriate rules and regulations.

Estrogens and Androgens in Skeletal Physiology and Pathophysiology.

A comprehensive review of the molecular and cellular mechanisms of action of estrogens and androgens on bone, their influences on skeletal homeostasis during growth and adulthood, the pathogenetic mechanisms of the adverse effects of their deficiency on the female and male skeleton, as well as the role of natural and synthetic estrogenic or androgenic compounds in the pharmacotherapy of osteoporosis is provided.

References

SHOWING 1-10 OF 53 REFERENCES

Effects of nandrolone decanoate on forearm mineral density and calcium metabolism in osteoporotic postmenopausal women

The results are consistent with the concept that nandrolone exerts a significant positive effect on bone formation and that this results in a fall in the fasting plasma calcium level, and consequently calcium excretion.

Effects of nandrolone therapy on forearm bone mineral content in osteoporosis.

Forearm bone mineral content (BMC) was measured sequentially on and off anabolic steroid therapy in 52 postmenopausal women with osteoporosis in what was a significant rise in BMC on nandrolone and a nonsignificant fall in BMC off n androlone.

Stanozolol in postmenopausal osteoporosis: therapeutic efficacy and possible mechanisms of action.

Intermittent cyclical etidronate treatment of postmenopausal osteoporosis.

Intermittent cyclical therapy with etidronate for two years significantly increases spinal bone mass and reduces the incidence of new vertebral fractures in women with postmenopausal osteoporosis.
...